Where do Stoke Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Stoke Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Operating margin	-577.5%-566pp	-11.2%-24.4pp	13.2%-6.9pp	20.2%+0.1pp	20%+297pp
Net margin	-529.2%-525pp	-3.7%-23.5pp	19.7%-6.5pp	26.3%-0.1pp	26.3%+270pp
Returns
Return on equity	-45.6%-43.2pp	-2.4%-17.4pp	15%-3.2pp	18.2%-2.3pp	20.5%+66.3pp
Return on invested capital	-114.4%-104pp	-10.9%-28.2pp	17.3%-10.1pp	27.4%—	——
Efficiency
Asset turnover	0.1×-0.5×	0.5×-0.1×	0.6×+0.1×	0.6×0.0×	0.6×+0.5×
Liquidity
Current ratio	9×+3.7×	5.3×-1.2×	6.5×-0.5×	7×-1.4×	8.4×+2.6×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$6.26+5.2%	$5.95+13.2%	$5.26-8.4%	$5.74-2.6%	$5.89+39.0%
Valuation
Market capitalization	$1.93B+6.2%	$1.81B+40.8%	$1.29B+105%	$628.41M+74.7%	$359.62M-38.4%
Price / sales	60×+50.2×	9.8×+3.6×	6.3×+3.1×	3.1×+1.3×	1.9×-14.1×
Price / book	4.9×-0.3×	5.1×+1.0×	4.2×+2.3×	1.9×+0.8×	1×-1.5×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Stoke Therapeutics, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Stoke Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Stoke Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.